Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Short term Debt (2016 - 2017)

Historic Short term Debt for Corcept Therapeutics (CORT) over the last 2 years, with Q2 2017 value amounting to $4.6 million.

  • Corcept Therapeutics' Short term Debt fell 7535.7% to $4.6 million in Q2 2017 from the same period last year, while for Jun 2017 it was $4.6 million, marking a year-over-year decrease of 7535.7%. This contributed to the annual value of $14.7 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Corcept Therapeutics reported Short term Debt of $4.6 million as of Q2 2017, which was down 7535.7% from $10.1 million recorded in Q1 2017.
  • Over the past 5 years, Corcept Therapeutics' Short term Debt peaked at $18.7 million during Q3 2016, and registered a low of $4.6 million during Q2 2017.